The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Clinical Presentation and Outcome of Patients with HIV Infection and Tuberculosis Caused by Multiple-Drug-resistant Bacilli

Margaret A. Fischl, MD; George L. Daikos, MD; Raj B. Uttamchandani, MD; Rita B. Poblete, MD; Jose N. Moreno, MD; Ricardo R. Reyes, MD; Ahmad M. Boota, MD; Lisa M. Thompson, BS, BME; Timothy J. Cleary, PhD; Sandra A. Oldham, MD; Mario J. Saldana, MD; and Shenghan Lai, PhD
[+] Article, Author, and Disclosure Information

Grant Support: In part by gifts from the Alliance Against AIDS and ANTRA.

Requests for Reprints: Margaret A. Fischl, MD, University of Miami School of Medicine, Department of Medicine, R-60A, P.O. Box 016960, Miami, FL 33101.

Current Author Addresses: Drs. Fischl, Daikos, Poblete, and Moreno: Department of Medicine, University of Miami School of Medicine, Miami, FL 33101.

Dr. Uttamchandani: F. Kevin Murphy and Associates, 9323 Garland Road, Dallas, TX 75218.

Dr. Reyes: Cleveland Clinic Florida, 3000 West Cypress Creek Road, Fort Lauderdale, FL 33109.

Dr. Boota: 412 Washington Street, Berkeley Springs, WV 25411. Ms. Thompson: AIDS Clinical Research Unit, Department of Medicine, University of Miami School of Medicine, Miami, FL 33101. Drs. Cleary and Saldana: Department of Pathology, University of Miami School of Medicine, Miami, FL 33101.

Dr. Oldham: Department of Radiology, University of Miami School of Medicine, Miami, FL 33101.

Dr. Lai: Comprehensive AIDS Program, University of Miami School of Medicine, Miami, FL 33101.

© 1992 American College of PhysiciansAmerican College of Physicians

Ann Intern Med. 1992;117(3):184-190. doi:10.7326/0003-4819-117-3-184
Text Size: A A A

Objective: To determine the clinical manifestations of patients with human immunodeficiency virus (HIV) infection and tuberculosis caused by multiple-drug-resistant bacilli compared with those with single-drug-resistant or susceptible bacilli.

Design: Descriptive, case-control, and cohort studies.

Setting: A large urban teaching hospital.

Patients: Sixty-two patients with tuberculosis caused by multiple-drug-resistant bacilli (cases) and 55 patients with tuberculosis caused by single-drug-resistant or susceptible bacilli (controls).

Measurements: Characteristics of clinical presentation, radiographs, pathologic abnormalities, antituberculosis treatment, and clinical course.

Results: Twenty cases (32%) had concomitant pulmonary and extrapulmonary disease at presentation compared with 9 controls (16%; odds ratio, 2.4; 95% Cl, 1.0 to 5.9). More cases had alveolar infiltrates (76%; odds ratio, 3.6; Cl, 1.2 to 11.4), interstitial infiltrates with a reticular pattern (67%; odds ratio, 7.8; Cl, 1.0 to 83.5), and cavitations (18%; odds ratio, 6.6; Cl, 0.8 to 315.3) on initial chest radiographs compared with controls (49%, 19%, and 3%, respectively). Pathologic specimens from cases showed extensive necrosis, poor granuloma formation, marked inflammatory changes with a predominance of neutrophils, and abundant acid-fast bacilli. Twenty-five cases received two or more effective antituberculosis drugs for more than 2 months. Only 2 cases had three consecutive negative cultures for Mycobacterium tuberculosis; one patient died within 1 day of the last negative culture, and the other had positive cultures 496 days later. The remaining 23 cases had persistently or intermittently positive cultures despite therapy. The clinical course of these cases suggested overwhelming miliary tuberculosis with involvement of the lungs (77%), pleura (15%), stool (34%), meninges (13%), bone marrow (16%), blood (10%), lymph nodes (10%), and skin (8%). The median survival time was 2.1 months for cases compared with 14.6 months for controls (P = 0.001, log-rank test).

Conclusions: Tuberculosis caused by multiple-drug-resistant bacilli in patients with HIV infection is associated with widely disseminated disease, poor treatment response with an inability to eradicate the organism, and substantial mortality.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $42.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.